Why ICH E6(R3) Readiness Is the Foundation of Future-Ready Clinical Trials
Introduction The clinical research industry is entering a new era where innovation, digital transformation, and patient-centric trial designs are redefining how studies are conducted. As these advancements continue to reshape the landscape, regulatory frameworks must evolve to ensure that participant safety and data integrity remain uncompromised. This evolution is reflected in ICH E6(R3), the latest…